New COVID-19 treatment option for non-hospitalised highest risk children and young people

Earlier this week, a new COVID-19 treatment became available across the UK for non-hospitalised children and young people aged 12 and over at the highest risk of severe COVID-19.

The UK-wide policy details those patients who are at the highest risk of severe disease and could be considered for treatment with Sotrovimab, a neutralising monoclonal antibody treatment. 

Visit the RCPCH website for full details

NHSE Letter re Contacting your patients about new COVID-19 treatments
Model letter for patients / families
British Academy of Childhood Disability is registered in England and Wales under charity number 1177868
Log in | Powered by White Fuse